Replies to post #72965 on DD Support Board and Research Team

[Alan Brochstein]

Janice, I didn't really spend a lot of time on any of the stocks that were suspended except for PHOT, CANN, AEGY/SKTO and FSPM. I never claimed to have looked into them deeply, and my cursory look at any of the others suggested not to waste my time. I warned investors publicly about FSPM on several occasions, but for other reasons than the apparent issue. On AEGY/SKTO, I pointed to several flaws to my own subscribers. I had no formal recommendation of CANN at the time of the suspension. I have never seen a good explanation for the PHOT suspension. Do you have one?

So, you think 30-day exclusivity is enough to compensate for the risks associated with filling out a Form 211?

[Art Vandeley]

I agree 100% there. It didn't take me more than a 5 minute glance at one 10q of PHOT's to see major red flags and I am not a professional analyst by any means.

If FRTD was the only one of those stocks Brochstein saw something wrong with, he just didn't look hard enough.